Liu, Hongyan http://orcid.org/0000-0003-3196-5756
Sridhar, Vikas S.
Perkins, Bruce A.
Rosenstock, Julio
Cherney, David Z. I.
Article History
Accepted: 29 March 2022
First Online: 28 May 2022
Declarations
:
: D.Z.I.C. has received consulting fees or speaking honorarium or both from Janssen, Bayer, Boehringer Ingelheim-Eli, Lilly, AstraZeneca, Merck & Co Inc, Prometic and Sanofi, and has received operating funds from Janssen, Boehringer Ingelheim-Eli, Lilly, Sanofi, AstraZeneca and Merck & Co Inc. B.A.P. has received speaker honoraria from Abbott, Medtronic, Insulet, and Novo-Nordisk; research support to his research institute from Boehringer Ingelheim, Novo Nordisk, and the Bank of Montreal (BMO), and has served as a consultant to Boehringer Ingelheim, Abbott, Insulet, and Novo-Nordisk. J.R. has served on advisory boards for Applied Therapeutics, Boehringer Ingelheim, Eli Lilly, Intarcia, Janssen, Novo Nordisk, Oramed, Sanofi, and Zealand; and has received research support from Applied Therapeutics, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Genentech, GlaxoSmithKline, Intarcia, Janssen, Lexicon, Merck, Novo Nordisk, Oramed, Pfizer and Sanofi. No potential conflicts of interest relevant to this article were reported for H.L. and V.S.S.